Cargando…

Age-Related Decrease in Abdominal Pain and Associated Structural- and Functional Mechanisms: An Exploratory Study in Healthy Individuals and Irritable Bowel Syndrome Patients

Introduction: The world population is ageing, resulting in increased prevalence of age-related comorbidities and healthcare costs. Limited data are available on intestinal health in elderly populations. Structural and functional changes, including altered visceroperception, may lead to altered bowel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beckers, Abraham B., Wilms, Ellen, Mujagic, Zlatan, Kajtár, Béla, Csekő, Kata, Weerts, Zsa Zsa R. M., Vork, Lisa, Troost, Freddy J., Kruimel, Joanna W., Conchillo, José M., Helyes, Zsuzsanna, Masclee, Ad A. M., Keszthelyi, Daniel, Jonkers, Daisy M. A. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716827/ https://www.ncbi.nlm.nih.gov/pubmed/34975501 http://dx.doi.org/10.3389/fphar.2021.806002

Ejemplares similares

Reduction in IBS symptom severity is not paralleled by improvement in quality of life in patients with irritable bowel syndrome
por: Weerts, Zsa Zsa R. M., et al.
Publicado: (2019)

Examining the optimal cutoff values of HADS, PHQ‐9 and GAD‐7 as screening instruments for depression and anxiety in irritable bowel syndrome
por: Snijkers, Johanna T. W., et al.
Publicado: (2021)

Integrated fecal microbiome–metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome
por: Mujagic, Zlatan, et al.
Publicado: (2022)

Smart Data Collection for the Assessment of Treatment Effects in Irritable Bowel Syndrome: Observational Study
por: Weerts, Zsa Zsa R M, et al.
Publicado: (2020)

Correction: Smart Data Collection for the Assessment of Treatment Effects in Irritable Bowel Syndrome: Observational Study
por: Weerts, Zsa Zsa R M, et al.
Publicado: (2021)

Digital Instruments for Reporting of Gastrointestinal Symptoms in Clinical Trials: Comparison of End-of-Day Diaries Versus the Experience Sampling Method
por: Beckers, Abraham B, et al.
Publicado: (2021)

The estimation of a preference-based single index for the IBS-QoL by mapping to the EQ-5D-5L in patients with irritable bowel syndrome
por: Sturkenboom, Rosel, et al.
Publicado: (2021)

Intestinal barrier function is maintained with aging – a comprehensive study in healthy subjects and irritable bowel syndrome patients
por: Wilms, Ellen, et al.
Publicado: (2020)

The Potential Role for Impaired Mucosal Integrity in the Generation of Esophageal Pain Using Capsaicin in Humans: An Explorative Study
por: Alleleyn, Annick M.E., et al.
Publicado: (2022)

A trial‐based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome
por: Weerts, Zsa Zsa R. M., et al.
Publicado: (2021)

Effect of Obesity on the Expression of Nutrient Receptors and Satiety Hormones in the Human Colon
por: Baumard, Lucas, et al.
Publicado: (2021)

The Experience Sampling Method—Evaluation of treatment effect of escitalopram in IBS with comorbid panic disorder
por: Vork, Lisa, et al.
Publicado: (2018)

Role of TRPV1 and TRPA1 Ion Channels in Inflammatory Bowel Diseases: Potential Therapeutic Targets?
por: Csekő, Kata, et al.
Publicado: (2019)

Patient-Specific Stress–Abdominal Pain Interaction in Irritable Bowel Syndrome: An Exploratory Experience Sampling Method Study
por: Vork, Lisa, et al.
Publicado: (2020)

Does Day-to-Day Variability in Stool Consistency Link to the Fecal Microbiota Composition?
por: Vork, Lisa, et al.
Publicado: (2021)

The Intestinal Barrier in Irritable Bowel Syndrome: Subtype-Specific Effects of the Systemic Compartment in an In Vitro Model
por: Ludidi, Samefko, et al.
Publicado: (2015)

Exploration of the Esophageal Mucosal Barrier in Non-Erosive Reflux Disease
por: Rinsma, Nicolaas F., et al.
Publicado: (2017)

Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study
por: Keszthelyi, Daniel, et al.
Publicado: (2012)

Using a Patient Hotel: Perceptions of the Quality of Care by Patients Undergoing Analysis for Gastrointestinal Motility Disorders in the Netherlands
por: Masclee, Gwen MC, et al.
Publicado: (2022)

Gastric peroral endoscopic pyloromyotomy for decompensated gastroparesis: comprehensive motility analysis in relation to treatment outcomes
por: Conchillo, José M., et al.
Publicado: (2021)

Antroduodenal motility recording identifies characteristic patterns in gastroparesis related to underlying etiology
por: Hereijgers, Maartje J. M., et al.
Publicado: (2022)

Ethanol Impairs Intestinal Barrier Function in Humans through Mitogen Activated Protein Kinase Signaling: A Combined In Vivo and In Vitro Approach
por: Elamin, Elhaseen, et al.
Publicado: (2014)

Upregulation of the TRPA1 Ion Channel in the Gastric Mucosa after Iodoacetamide-Induced Gastritis in Rats: A Potential New Therapeutic Target
por: Csekő, Kata, et al.
Publicado: (2020)

A novel biomarker panel for irritable bowel syndrome and the application in the general population
por: Mujagic, Zlatan, et al.
Publicado: (2016)

Translational Difficulties in Studying the TRPA1 Receptor
por: Keszthelyi, Daniel, et al.
Publicado: (2016)

Safety of chronic hypertonic bicarbonate inhalation in a cigarette smoke-induced airway irritation guinea pig model
por: Csekő, Kata, et al.
Publicado: (2022)

Therapeutic strategies in gastroparesis: Results of stepwise approach with diet and prokinetics, Gastric Rest, and PEG‐J: A retrospective analysis
por: Strijbos, Denise, et al.
Publicado: (2019)

Colonoscopy is safe and not associated with higher pain scores in patients with hypermobility spectrum disorder: results from an exploratory prospective study
por: Beckers, Abraham B., et al.
Publicado: (2020)

The Impact of Pectin Supplementation on Intestinal Barrier Function in Healthy Young Adults and Healthy Elderly
por: Wilms, Ellen, et al.
Publicado: (2019)

Diet Quality and Dietary Inflammatory Index in Dutch Inflammatory Bowel Disease and Irritable Bowel Syndrome Patients
por: de Graaf, Marlijne C. G., et al.
Publicado: (2022)

Measurement of Esophagogastric Junction Distensibility May Assist in Selecting Patients for Endoluminal Gastroesophageal Reflux Disease Surgery: Author’s Reply
por: Smeets, Fabiënne G M, et al.
Publicado: (2015)

Patient preferences of healthcare delivery in irritable bowel syndrome: a focus group study
por: Masclee, Gwen M. C., et al.
Publicado: (2021)

The Intake of Dicarbonyls and Advanced Glycation Endproducts as Part of the Habitual Diet Is Not Associated with Intestinal Inflammation in Inflammatory Bowel Disease and Irritable Bowel Syndrome Patients
por: de Graaf, Marlijne C. G., et al.
Publicado: (2022)

Systematic Review: Contribution of the Gut Microbiome to the Volatile Metabolic Fingerprint of Colorectal Neoplasia
por: van Vorstenbosch, Robert, et al.
Publicado: (2022)

Psychometric evaluation of an experience sampling method–based patient‐reported outcome measure in functional dyspepsia
por: Klaassen, Tim, et al.
Publicado: (2021)

Do Patients’ and Physicians’ Perspectives Differ on Preferences for Irritable Bowel Syndrome Treatment?
por: Sturkenboom, Rosel, et al.
Publicado: (2022)

Stool Consistency: Looking Beyond the Bristol Stool Form Scale
por: Vork, Lisa, et al.
Publicado: (2019)

Intraduodenal Administration of Intact Pea Protein Effectively Reduces Food Intake in Both Lean and Obese Male Subjects
por: Geraedts, Maartje C. P., et al.
Publicado: (2011)

Does Measurement of Esophagogastric Junction Distensibility by EndoFLIP Predict Therapy-responsiveness to Endoluminal Fundoplication in Patients With Gastroesophageal Reflux Disease?
por: Smeets, Fabiënne G M, et al.
Publicado: (2015)

Fatty Acid Ethyl Esters Induce Intestinal Epithelial Barrier Dysfunction via a Reactive Oxygen Species-Dependent Mechanism in a Three-Dimensional Cell Culture Model
por: Elamin, Elhaseen, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3a3ar2idv10c7cltf0bsu28e0b